Cellectis (CLLS) Stock Chart & Stock Price History $1.40 -0.02 (-1.40%) As of 01:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectis Stock Price Performance The Cellectis (CLLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.33%, with a year-to-date return of -21.94%. In the past month, the stock has decreased 12.19%, reflecting recent market activity. As of the latest close, Cellectis traded at $1.43 with a market cap of $79.21 million and volume of 70,158 shares. Five years ago, the stock traded at $16.92, representing a 91.70% decrease over that period. At the time, it had a market cap of $718.53 million and a volume of 251,900 shares. Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.77%1 Month Performance-12.19%3 Month Performance+15.16%Year-To-Date Performance-21.94%1 Year Performance-45.33%5 Year Performance-91.70% CLLS Stock Chart for Tuesday, June, 10, 2025 CLLS Chart by TradingView Cellectis Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/09/2025$1.41$1.43+1.06%$1.46$1.3970,158 shs$79.21 million06/06/2025$1.45$1.41-2.42%$1.49$1.3770,273 shs$78.37 million06/05/2025$1.43$1.45+1.05%$1.48$1.42110,371 shs$80.32 million06/04/2025$1.46$1.43-2.05%$1.47$1.4247,733 shs$79.49 million06/03/2025$1.49$1.46-2.01%$1.51$1.4515,731 shs$81.15 million06/02/2025$1.45$1.49+2.97%$1.55$1.4741,664 shs$82.82 million05/30/2025$1.44$1.45+0.49%$1.47$1.41103,936 shs$80.43 million05/29/2025$1.41$1.44+2.13%$1.48$1.4169,672 shs$80.04 million05/28/2025$1.46$1.41-3.42%$1.48$1.4139,491 shs$78.37 million05/27/2025$1.47$1.46-0.68%$1.52$1.4564,287 shs$81.15 million Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 05/26/2025$1.47$1.47$1.60$1.4749,606 shs$81.71 million05/23/2025$1.56$1.47-5.47%$1.60$1.4749,606 shs$81.71 million05/22/2025$1.52$1.56+2.30%$1.57$1.4821,953 shs$86.43 million05/21/2025$1.54$1.52-1.30%$1.57$1.4868,468 shs$84.49 million05/20/2025$1.55$1.54-0.65%$1.56$1.4629,630 shs$85.60 million05/19/2025$1.58$1.55-1.90%$1.58$1.5325,191 shs$86.16 million05/16/2025$1.46$1.58+8.22%$1.58$1.4749,716 shs$87.82 million05/15/2025$1.38$1.46+5.80%$1.50$1.4225,319 shs$81.15 million05/14/2025$1.41$1.38-2.13%$1.51$1.3727,973 shs$76.71 million05/13/2025$1.51$1.41-6.62%$1.45$1.4152,790 shs$78.37 million05/12/2025$1.60$1.51-5.63%$1.58$1.4624,659 shs$83.93 million05/09/2025$1.53$1.60+4.58%$1.60$1.5324,192 shs$88.93 million Related Companies IVA Stock Price Chart PHAT Stock Price Chart AURA Stock Price Chart TRDA Stock Price Chart TKNO Stock Price Chart OLMA Stock Price Chart CMPX Stock Price Chart RCKT Stock Price Chart HRTX Stock Price Chart ACB Stock Price Chart Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLLS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery This might just be the greatest time in America to be an energy company. Since taking office in 2025, Presi...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLLS Stock Free CLLS Stock Alerts